However, there were a handful of known studies with CD4 T cells related signatures, such as CD4+ conventional T cells-related lncRNA signature in breast cancer and hepatocellular carcinoma prognosis (23, 24). This evidence concerns the gene CD4 and hepatocellular carcinoma.